Title : Exceptional Response of Metastatic Chromophobe Renal Cell Carcinoma to Vascular Endothelial Growth Factor (VEGF) Inhibitors: Should Increased VEGF-C Expression Be Used to Guide Treatment?

Pub. Date : 2019

PMID : 31956465






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The tyrosine kinase inhibitor (TKI) sunitinib selectively inhibits the VEGF pathway and it is a standard care for metastatic clear cell renal cell carcinoma (ccRCC), although data supporting its use in ChRCC is much more limited. Tyrosine vascular endothelial growth factor A Homo sapiens